Biblio
Export 391 results:
Author [ Title] Type Year Filters: First Letter Of Last Name is O [Clear All Filters]
“A 10-Year Follow-Up of Adiposity and Dementia in Swedish Adults Aged 70 Years and Older.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1325-1335, 2018.
, “18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease.”, Brain, vol. 134, no. Pt 4, pp. 1089-100, 2011.
, “18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease.”, Brain, vol. 134, no. Pt 4, pp. 1089-100, 2011.
, “Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study.”, J Alzheimers Dis, vol. 59, no. 1, pp. 339-358, 2017.
, “Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study.”, J Alzheimers Dis, vol. 59, no. 1, pp. 339-358, 2017.
, “Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases.”, J Alzheimers Dis, vol. 62, no. 1, pp. 247-268, 2018.
, “Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases.”, J Alzheimers Dis, vol. 62, no. 1, pp. 247-268, 2018.
, “Acceleration of Amyloidosis by Inflammation in the Amyloid-Beta Marmoset Monkey Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 1, pp. 101-113, 2017.
, “Is Acculturation Associated with the Cognitive Performance of Older Hispanics?”, J Alzheimers Dis, vol. 85, no. 2, pp. 535-544, 2021.
, “Activation of TNF Receptor 2 Improves Synaptic Plasticity and Enhances Amyloid-β Clearance in an Alzheimer's Disease Mouse Model with Humanized TNF Receptor 2.”, J Alzheimers Dis, vol. 94, no. 3, pp. 977-991, 2023.
, “Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 71, no. 1, pp. 281-290, 2019.
, “Aerosol Delivery of Curcumin Reduced Amyloid-β Deposition and Improved Cognitive Performance in a Transgenic Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 797-811, 2017.
, “Age of Migration and Cognitive Function Among Older Latinos in the United States.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1493-1511, 2020.
, “Age-Related Association Between APOE ɛ4 and Cognitive Progression in de novo Parkinson's Disease.”, J Alzheimers Dis, vol. 91, no. 3, pp. 1121-1132, 2023.
, “Age-Related Effects of the Apolipoprotein E Gene on Brain Function.”, J Alzheimers Dis, vol. 52, no. 1, pp. 317-31, 2016.
, “Algoplus® Scale in Older Patients with Dementia: A Reliable Real-World Pain Assessment Tool.”, J Alzheimers Dis, vol. 56, no. 2, pp. 519-527, 2017.
, “Allocentric and Egocentric Spatial Processing in Middle-Aged Adults at High Risk of Late-Onset Alzheimer's Disease: The PREVENT Dementia Study.”, J Alzheimers Dis, vol. 65, no. 3, pp. 885-896, 2018.
, “Alteration of Gut Microbiota in Alzheimer's Disease and Their Relation to the Cognitive Impairment.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1103-1114, 2022.
, “Alterations in Phase-Related Prefrontal Activation During Cognitive Tasks and Nicotinic α4β2 Receptor Availability in Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 3, pp. 817-30, 2016.
, “Alterations in Phase-Related Prefrontal Activation During Cognitive Tasks and Nicotinic α4β2 Receptor Availability in Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 3, pp. 817-30, 2016.
, “Altered Topology in Information Processing of a Narrated Story in Older Adults with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 53, no. 2, pp. 517-33, 2016.
, “Aluminum and Neurofibrillary Tangle Co-Localization in Familial Alzheimer's Disease and Related Neurological Disorders.”, J Alzheimers Dis, vol. 78, no. 1, pp. 139-149, 2020.
, “Alzheimer's and Parkinson's Diseases and the Risk of Cancer: A Cohort Study.”, J Alzheimers Dis, vol. 72, no. 4, pp. 1269-1277, 2019.
, “Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.”, J Alzheimers Dis, vol. 62, no. 3, pp. 965-992, 2018.
, “Alzheimer's Disease: Key Insights from Two Decades of Clinical Trial Failures.”, J Alzheimers Dis, vol. 87, no. 1, pp. 83-100, 2022.
,